Alnylam Pharmaceuticals experienced a significant surge in its stock price, jumping by over 32%, following the successful outcomes of its drug vutrisiran in...
By 193cc Agency CouncilJune 25, 2024Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...
By 193cc Agency CouncilApril 5, 2024In the dynamic world of pharmaceuticals, the journey of Xu Jiangnan stands out as a beacon of innovation, perseverance, and strategic foresight. As...
By 193cc World's BillionairesMarch 5, 2024In the ever-evolving landscape of global healthcare, few figures have made as indelible a mark as Feng Yuxia, the visionary chair of Joinn...
By 193cc World's BillionairesFebruary 27, 2024